Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us
china’s-surging-biotech-sector-represents-both-competition-and-lifeline-for-the-us
ChinaClinical Research

China’s surging biotech sector represents both competition and lifeline for the US

Emerging from stealth earlier this month, Boston-based Solstice Oncology highlighted its origins in a trans-Pacific exchange that’s grown commonplace. The startup licensed its lead asset,…

byadminSeptember 23, 2026
fda-raises-bar-for-foreign-site-inspections-as-china-trials-surge
Clinical Researchraises

FDA raises bar for foreign site inspections as China trials surge

byadminSeptember 2, 2026
tavneos-no-longer-available-for-new-patients-in-uk-as-amgen-awaits-fda-hearing
Clinical ResearchTavneos

Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing

byadminSeptember 2, 2026

Science

View All
scientists-tracked-kids-for-8-years.-what-they-found-about-screen-time-was-surprising
AI in BiotechnologyScientists

Scientists tracked kids for 8 years. What they found about screen time was surprising

byadminNovember 17, 2026
yale-scientists-reveal-what-really-slows-aging-and-what-doesn’t
Research and DiscoveryScientists

Yale scientists reveal what really slows aging and what doesn’t

byadminNovember 14, 2026
scientists-solve-30-year-old-mystery-and-discover-a-hidden-defense-against-inflammation
Research and DiscoveryScientists

Scientists solve 30-year-old mystery and discover a hidden defense against inflammation

byadminNovember 5, 2026

Latest

View All
ptsd-brain-dna-methylation-patterns-linked-to-age-of-trauma-exposure,-sex,-and-ethnicity

PTSD Brain DNA Methylation Patterns Linked to Age of Trauma Exposure, Sex, and Ethnicity

byadminNovember 20, 2026
immune-aging-study-in-mice-reveals-clues-to-t-cell-dysfunction-and-cancer-development

Immune Aging Study in Mice Reveals Clues to T Cell Dysfunction and Cancer Development

byadminNovember 20, 2026
genome-writing-inserts-human-x-linked-disease-dna-into-mice

Genome Writing Inserts Human X-Linked Disease DNA Into Mice

byadminNovember 20, 2026
former-verily-leaders-build-ai-platform-to-get-more-from-proteomics-data

Former Verily Leaders Build AI Platform to Get More from Proteomics Data

byadminNovember 19, 2026
type-1-diabetes-delayed-in-mice-by-stem-cell-derived-vesicles-that-calm-immune-response

Type 1 Diabetes Delayed in Mice by Stem Cell-Derived Vesicles That Calm Immune Response

byadminNovember 19, 2026
AI may not work like the human brain after all, scientists discover
AI in Biotechnologyhuman

AI may not work like the human brain after all, scientists discover

Artificial intelligence may be much less like the human brain than scientists have long assumed. A new study from York…

byadminNovember 21, 2026
Capricor’s regulatory odyssey for DMD cell therapy hits second FDA rejection
Capricor’sResearch and Discovery

Capricor’s regulatory odyssey for DMD cell therapy hits second FDA rejection

The FDA left Capricor Therapeutics assessing its options yet again after issuing a second rejection for the biotech’s cell therapy…

byadminNovember 21, 2026
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Globenewswire

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy

Company receives Complete Response Letter from FDA for Deramiocel BLA Conference call and webcast Monday, November 23, at 8:30 a.m.…

byadminNovember 21, 2026
Alps Group Inc Regains Compliance with Nasdaq Minimum Bid Price Requirement
Globenewswire

Alps Group Inc Regains Compliance with Nasdaq Minimum Bid Price Requirement

KUALA LUMPUR, Malaysia, Nov. 20, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated…

byadminNovember 20, 2026
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Globenewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PHILADELPHIA, Nov. 20, 2026 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a commercial biotechnology company…

byadminNovember 20, 2026
Theriva™ Biologics Announces Reverse Stock Split
Globenewswire

Theriva™ Biologics Announces Reverse Stock Split

ROCKVILLE, Md., Nov. 20, 2026 (GLOBE NEWSWIRE) — Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics…

byadminNovember 20, 2026
Abivax Statement on Short Seller Report
Globenewswire

Abivax Statement on Short Seller Report

Abivax Statement on Short Seller Report PARIS, France – November 20, 2026 – 10:30 PM CET – Abivax SA (Euronext…

byadminNovember 20, 2026
Teva to Present at the 9th Annual Evercore Healthcare Conference, the Piper Sandler 38th Annual Healthcare Conference and Citi’s 2026 Global Healthcare Conference
Globenewswire

Teva to Present at the 9th Annual Evercore Healthcare Conference, the Piper Sandler 38th Annual Healthcare Conference and Citi’s 2026 Global Healthcare Conference

TEL AVIV, Israel and PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)…

byadminNovember 20, 2026
BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences Innovation
PR Newswire

BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences Innovation

, /PRNewswire/ — Bon Natural Life Limited (NASDAQ: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the…

byadminNovember 20, 2026
Kymera Therapeutics to Announce KT-621 BROADEN2 Phase 2b Atopic Dermatitis Trial Results on November 23, 2026
Globenewswire

Kymera Therapeutics to Announce KT-621 BROADEN2 Phase 2b Atopic Dermatitis Trial Results on November 23, 2026

Company to host video conference call and webcast at 8:00 a.m. ET on Monday, November 23, 2026 WATERTOWN, Mass., Nov.…

byadminNovember 20, 2026

Posts pagination

1 2 … 282 Next

| Depth News by Ascendoor | Powered by WordPress.